Pediatrix files Form 144 to resell 36,028 restricted shares

Pediatrix Medical Group, Inc. submitted a Form 144 notice via Robert W. Baird & Co. proposing the resale of restricted common shares tied to compensatory vesting.

Rhea-AI Filing Summary

Pediatrix Medical Group, Inc. submitted a Form 144 notice via Robert W. Baird & Co. proposing the resale of restricted common shares tied to compensatory vesting.

The excerpt lists proposed shares associated with four vesting dates: 07/12/2021 (2,926 shares), 07/12/2023 (3,777), 05/11/2024 (10,965), and 05/09/2025 (18,360); aggregate appears as 36,028 shares.

Insights

Capital Markets Analyst

Form 144 lists proposed resale of restricted shares totaling 36,028.

The filing shows planned resale of restricted common stock tied to prior compensatory vesting events dated 07/12/2021, 07/12/2023, 05/11/2024, and 05/09/2025. The broker listed is Robert W. Baird & Co.

These notices permit a holder to comply with resale conditions under the rule; actual sale timing and method are not disclosed in the excerpt. Subsequent filings would show executed transactions.

Key Figures

Aggregate shares listed: 36,028 shares Vesting date 1: 2,926 shares Vesting date 2: 3,777 shares +2 more

5 metrics

Aggregate shares listed 36,028 shares total shown in header of excerpt

Vesting date 1 2,926 shares <date>07/12/2021</date>

Vesting date 2 3,777 shares <date>07/12/2023</date>

Vesting date 3 10,965 shares <date>05/11/2024</date>

Vesting date 4 18,360 shares <date>05/09/2025</date>

Key Terms

Restricted Stock Vest, Form 144, Compensatory Payment

3 terms

Restricted Stock Vest financial

"Common | 07/12/2021 | Restricted Stock Vest | Pediatrix Medical Group, Inc."

A restricted stock vest is the moment when shares granted to an employee or executive under conditions (like staying at the company or hitting targets) officially become theirs to keep or sell. Think of it as a timed gift that unlocks only after certain rules are met. Investors watch vesting because it can change who controls shares, create potential selling pressure when large blocks unlock, and reveal how management’s incentives are aligned with company performance.

Form 144 regulatory

"CONTENT METADATA: "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Compensatory Payment financial

"07/12/2021 | Compensatory Payment Common"

FAQ

What does Pediatrix Medical Group's (MD) Form 144 report?

The Form 144 reports a proposed resale of restricted common shares. It lists 36,028 shares associated with four vesting dates and names Robert W. Baird & Co. as the broker handling the notice.

How many shares are listed for resale on the Form 144 for MD?

The filing shows an aggregate of 36,028 shares. Line items list 2,926, 3,777, 10,965, and 18,360 tied to specific vesting dates.

Are the shares in the Form 144 newly issued or from compensation vesting for MD?

The shares are tied to restricted stock vesting and labeled as Compensatory Payment, indicating they relate to prior equity compensation rather than a primary issuance.

Does this Form 144 mean the shares have already been sold?

No. The Form 144 is a notice of proposed resale under the rule. The excerpt shows proposed amounts and vesting dates; it does not confirm completed sales or sale timing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 08:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001623324
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pediatrix Medical Group, Inc.
SEC File Number	001-12111
Address of Issuer	1301 CONCORD TERRACE SUNRISE FLORIDA 33323
Phone	9543840175
Name of Person for Whose Account the Securities are To Be Sold	Weis Shirley A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Robert W. Baird & Co. 777 E. Wisconsin Avenue Milwaukee WI 53202	36028	853143.04	82121911	05/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/12/2021	Restricted Stock Vest	Pediatrix Medical Group, Inc.			2926	07/12/2021	Compensatory Payment
Common	07/12/2023	Restricted Stock Vest	Pediatrix Medical Group, Inc.			3777	07/12/2023	Compensatory Payment
Common	05/11/2024	Restricted Stock Vest	Pediatrix Medical Group, Inc.			10965	05/11/2024	Compensatory Payment
Common	05/09/2025	Restricted Stock Vest	Pediatrix Medical Group, Inc.			18360	05/09/2025	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares reported herein were sold for the account of The Weis Family Trust U/A dtd 04/19/2002, John N. Weis & Shirley A. Weis Trustees (the "Trust"). The Reporting Person and her husband are trustees of the Trust. Members of the Reporting Person's immediate family are beneficiaries of the Trust.
Date of Notice	05/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shirley Weis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)